Table 1 The reagents used in the study
From: Downregulation of TUSC3 promotes EMT and hepatocellular carcinoma progression through LIPC/AKT axis
Antibody | Source | Identifiers |
|---|---|---|
TUSC3 | Proteintech, China | 1:800, #16039 |
LIPC | Proteintech, China | 1:500, #21133 |
β-tubulin | Proteintech, China | 1:2000, #10068 |
pAKT | Cell Signaling Technology, America | 1:1000, #9271 |
AKT | Cell Signaling Technology, America | 1:1000, #9272 |
E-cadherin | Proteintech, China | 1:1000, #20874 |
N-cadherin | Proteintech, China | 1:1000, #22018 |
Vimentin | Proteintech, China | 1:1000, #10366 |
MK2206 inhibitor | Proteintech, China | 5Â mg, #S1078 |